Ferring launches nocturia drug for adults of all ages
Ferring Pharmaceuticals has launched Noqdirna in the UK, offering the only licensed treatment for the symptomatic treatment of nocturia due to nocturnal polyuria in adults of all ages.
Read More
Tag: Noqdirna
- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
